Dario Picone

Dario Picone

Auto-generated profile, based on publicly available information

Dario Picone

Section of Radiology-Di.Bi.Med., University of Palermo, Palermo, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2016 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
GRGiuseppe Lo Re
Giuseppe Lo Re
RLRossella De Luca
Rossella De Luca
FMFilippa Muscarneri
Filippa Muscarneri
PDPatrizia Dorangricchia
Patrizia Dorangricchia
DPDario Picone
Dario Picone
GCGiuseppe Cicero
Giuseppe Cicero

24 December 2015 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
GRGiuseppe Lo Re
Giuseppe Lo Re
Federica VernuccioFederica Vernuccio
Federica Vernuccio
FMFederico Midiri
Federico Midiri
DPDario Picone
Dario Picone
GTGiuseppe La Tona
Giuseppe La Tona
MMMassimo Midiri
Massimo Midiri
Gastrointestinal lymphomas represent 5–20% of extranodal lymphomas and mainly occur in the stomach and small intestine. Clinical findings are not specific, thus often determining a delay in the diagnosis. Imaging features at conventional and cross-sectional imaging must be known by the radiologist since he/she plays a pivotal role in the diagnosis and disease assessment, thus assisting in the choice of the optimal treatment to patients. This review focuses on the wide variety of imaging presentation of esophageal, gastric, and small and large bowel lymphoma presenting their main imaging appearances at conventional and cross-sectional imaging, mainly focusing on computed tomography and magnetic resonance, helping in the choice of the best imaging technique for the disease characterization and assessment and the recognition of potential complications.

1 June 2016
Verified
Journal Article
Closed access
Federica VernuccioFederica Vernuccio
Federica Vernuccio
ATAdele Taibbi
Adele Taibbi
DPDario Picone
Dario Picone
LGLudovico La Grutta
Ludovico La Grutta
MMMassimo Midiri
Massimo Midiri
TBTommaso Vincenzo Bartolotta
Tommaso Vincenzo Bartolotta

11 July 2014 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
GRGiuseppe Lo Re
Giuseppe Lo Re
Federica VernuccioFederica Vernuccio
Federica Vernuccio
MGMaria Cristina Galfano
Maria Cristina Galfano
DPDario Picone
Dario Picone
LMLivio Milone
Livio Milone
RLRoberto Lagalla
Roberto Lagalla

7 December 2015 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
GRGiuseppe Lo Re
Giuseppe Lo Re
CTChiara Tudisca
Chiara Tudisca
Federica VernuccioFederica Vernuccio
Federica Vernuccio
DPDario Picone
Dario Picone
MCMaria Cappello
Maria Cappello
RLRoberto Lagalla
Roberto Lagalla

1 April 2017 in Ultrasonography
Verified
Journal Article
Open access
PDF file
TBTommaso Vincenzo Bartolotta
Tommaso Vincenzo Bartolotta
ATAdele Taibbi
Adele Taibbi
DPDario Picone
Dario Picone
AAAndrea Anastasi
Andrea Anastasi
MMMassimo Midiri
Massimo Midiri
RLRoberto Lagalla
Roberto Lagalla
The aim of this study is to assess the role of contrast-enhanced ultrasonography (CEUS) in the detection of liver metastases in cancer patients with geographic liver fatty deposition on greyscale ultrasonography (US). Thirty-seven consecutive cancer patients (24 women and 13 men; age, 33 to 80 years; mean, 58.1 years) with geographic liver fatty deposition, but without any detectable focal liver lesion on greyscale US, underwent sulphur hexafluoride-enhanced US. Two readers reported by consensus the presence, size, and location of any detected lesion. All patients underwent magnetic resonance imaging (MRI) as a confirmatory study. Sensitivity, specificity, positive and negative predictive values (PPV and NPV), and accuracy were calculated. Seven focal liver lesions (size, 4 to 10 mm; mean, 6.1 mm) were detected in 4/37 patients (10.8%): four metastases (size, 5 to 10 mm; mean, 6.7 mm) were detected both by CEUS and MRI, with one hemangioma and two cysts (size range, 4 to 6 mm; mean, 5.3 mm) detected by MRI only. In 1/37 patients (2.7%), CEUS misdiagnosed geographic fatty change as three metastases. In 32/37 patients (86.5%), no lesions were detected. Sensitivity, specificity, PPV, NPV, and accuracy of CEUS were 100% (95% confidence Interval [CI], 1.000 to 1.000), 97.1% (95% CI, 0.914 to 1.027), 75%, 100%, and 97.3%, respectively. No statistically significant differences were found between CEUS and MRI in the detection of focal liver lesions (P=0.480), whereas both of them performed better than baseline US (P<0.001). CEUS improves the detection of liver metastases in cancer patients with geographic liver fatty deposition on greyscale US.